Aspectos Clínicos y Epidemiológicos del VIH y Condiciones Asociadas

Tejerina, F; de Quiros, JCLB.

Protease Inhibitors as Preferred Initial Regimen for Antiretroviral-Naive HIV Patients

AIDS REVIEWS. 2011; 13(4): 227-233 Nº de citas: 10

Guzman-Fulgencio, M; Berenguer, J; Garcia-Alvarez, M; Micheloud, D; Lopez, JC; Cosin, J; de Castro, IF; Catalan, P; Miralles, P; Resino, S.

Soluble Fas and Fas ligand in HIV/HCV coinfected patients and impact of HCV therapy

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES. 2011; 30(10): 1213-1221 Nº de citas: 4 [doi:10.1007/s10096-011-1215-0]

Garcia-Alvarez, M; Guzman-Fulgencio, M; Berenguer, J; Micheloud, D; Campos, Y; Lopez, JC; Cosin, J; Miralles, P; Alvarez, E; Resino, S.

European mitochondrial DNA haplogroups and liver fibrosis in HIV and hepatitis C virus coinfected patients

AIDS. 2011; 25(13): 1619-1626 Nº de citas: 14 [doi:10.1097/QAD.0b013e328349820f]

Sanchez-Conde, M; Ramirez, MLM; Cano, JMB; Caminoa, A; Rodriguez, FA; Garcia, JG; Martin, PM; de la Serna, IB; de Quiros, JCLB; Lopez, JRA; Ochaita, JC; Pareja, JFP; Alvarez, E; Berenguer, JB.

Impact of liver steatosis on the correlation between liver stiffness and fibrosis measured by transient elastography in patients coinfected with human immunodeficiency virus and hepatitis C virus

JOURNAL OF VIRAL HEPATITIS. 2011; 18(7): 278-283 Nº de citas: 32 [doi:10.1111/j.1365-2893.2010.01407.x]

Cachafeiro, SP; Caro-Murillo, AM; Berenguer, J; Segura, F; Gutierrez, F; Vidal, F; Martinez-Perez, MA; Sola, J; Muga, R; Moreno, S; Del Amo, J.

Association of Patients' Geographic Origins with Viral Hepatitis Co-infection Patterns, Spain

EMERGING INFECTIOUS DISEASES. 2011; 17(6): 1116-1119 Nº de citas: 6 [doi:10.3201/eid1706.091810]

Garcia-Alvarez, M; Berenguer, J; Guzman-Fulgencio, M; Micheloud, D; Catalan, P; Munoz-Fernandez, MA; Alvarez, E; Resino, S.

High plasma fractalkine (CX3CL1) levels are associated with severe liver disease in HIV/HCV co-infected patients with HCV genotype 1

CYTOKINE. 2011; 54(3): 244-248 Nº de citas: 17 [doi:10.1016/j.cyto.2011.03.001]

Lopez-Dieguez, M; Montes, ML; Pascual-Pareja, JF; Quereda, C; Von Wichmann, MA; Berenguer, J; Tural, C; Hernando, A; Gonzalez-Garcia, J; Serrano, L; Arribas, JR.

The natural history of liver cirrhosis in HIV-hepatitis C virus-coinfected patients

AIDS. 2011; 25(7): 899-904 Nº de citas: 65 [doi:10.1097/QAD.0b013e3283454174]

Guzman-Fulgencio, M; Berenguer, J; de Castro, IF; Micheloud, D; Lopez, JC; Cosin, J; Miralles, P; Lorente, R; Aldamiz-Echevarria, T; Munoz-Fernandez, MA; Resino, S.

Sustained virological response to interferon-alpha plus ribavirin decreases inflammation and endothelial dysfunction markers in HIV/HCV co-infected patients

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY. 2011; 66(3): 645-649 Nº de citas: 27 [doi:10.1093/jac/dkq518]

Alonso, M; Rodriguez-Sanchez, B; Giannella, M; Catalan, P; Gayoso, J; de Quiros, JCLB; Bouza, E; de Viedma, DG.

Resistance and virulence mutations in patients with persistent infection by pandemic 2009 A/H1N1 influenza

JOURNAL OF CLINICAL VIROLOGY. 2011; 50(2): 114-118 Nº de citas: 21 [doi:10.1016/j.jcv.2010.10.007]

Resino, S; Seoane, JA; Bellon, JM; Dorado, J; Martin-Sanchez, F; Alvarez, E; Cosin, J; Lopez, JC; Lopez, G; Miralles, P; Berenguer, J.

An artificial neural network improves the non-invasive diagnosis of significant fibrosis in HIV/HCV coinfected patients

JOURNAL OF INFECTION. 2011; 62(1): 77-86 Nº de citas: 29 [doi:10.1016/j.jinf.2010.11.003]

Parra, J; Portilla, J; Pulido, F; Sanchez-de la Rosa, R; Alonso-Villaverde, C; Berenguer, J; Blanco, JL; Domingo, P; Dronda, F; Galera, C; Gutierrez, F; Kindelan, JM; Knobel, H; Leal, M; Lopez-Aldeguer, J; Marino, A; Miralles, C; Molto, J; Ortega, E; Oteo, JA.

Clinical Utility of Maraviroc

CLINICAL DRUG INVESTIGATION. 2011; 31(8): 527-542 Nº de citas: 26 [doi:10.2165/11590700-000000000-00000]

Tural, C; Sola, R; Alvarez, NP; Molto, J; Sanchez, M; Zamora, AM; Ornelas, A; Laguno, M; Gonzalez, J; von Wichmann, MA; Tellez, MJ; Paredes, R; Clotet, B.

Effect of an induction period of pegylated interferon-alpha 2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study

ANTIVIRAL THERAPY. 2011; 16(6): 833-841 Nº de citas: 1 [doi:10.3851/IMP1837]